Evidence map›Paper›PMID 39184446›Full record

ArticleiScience2024

A high-throughput screening identifies MCM chromatin loading inhibitors targeting cells with increased replication origins.

Lucia Falbo, Hervé Técher, Vincenzo Sannino, Michela Robusto, Giovanni Fagà, Federica Pezzimenti, Francesco Romeo, Luca Gabriele Colombo, Stefania Vultaggio, Daniele Fancelli and 6 more

Abstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Lucia FalboIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Hervé TécherIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Vincenzo SanninoIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Michela RobustoIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Giovanni FagàIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Federica PezzimentiIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Francesco RomeoIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Luca Gabriele ColomboIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Stefania VultaggioIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Daniele FancelliIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Silvia MonzaniDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.
Valentina CecatielloDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.
Sebastiano PasqualatoDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.
Mario VarasiIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Ciro MercurioIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Vincenzo CostanzoIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Replication origin assembly is a pivotal step in chromosomal DNA replication. In this process, the ORC complex binds DNA and, together with the CDC6 and CDT1, promotes the loading of the MCM helicase. Chemicals targeting origin assembly might be useful to sensitize highly proliferative cancer cells. However, identifying such compounds is challenging due to the multistage nature of this process. Here, using

Indexed as

BiochemistryCell biologyMolecular biology

Identifiers

PMID39184446
PMCPMC11342271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.